Ecolab (ECL) Could Be 17% Undervalued Before June Earnings

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge.

Wall Street expectations for Ecolab (ECL) ahead of its June 2026 quarterly report are in focus, with analysts projecting earnings of $2.08 per share on revenue of about $4.4 billion.

See our latest analysis for Ecolab.

Ecolab's share price has eased in recent sessions, with a 7 day share price return down 4.56% and a 90 day share price return down 2.36%, while the 3 year total shareholder return of 47.69% points to stronger longer term momentum.

If Ecolab is on your radar because of upcoming earnings, this can be a good moment to broaden your watchlist and check out 17 top founder-led companies

Bulls point to Ecolab's steady revenue and earnings picture, while bears flag the recent share price softness and analyst estimate cuts. Which side does the valuation actually support as earnings approach?

Most Popular Narrative: 17% Undervalued

At a last close of $263.14 versus a narrative fair value of about $317, the current gap on Ecolab centers on how durable its growth and margin story really is.

Life Sciences is positioned for accelerated long term growth, with mid single digit sales growth and significant share gains in its biopharma business. Investments in innovation and capacity expansion are anticipated to achieve operating income margins close to 30%, positively affecting long term earnings potential.

Read the complete narrative.

Want to see the math behind that valuation gap? The narrative leans on rising margins, steady top line progress, and a future earnings profile that commands a premium multiple. Curious which assumptions really move that fair value?

Result: Fair Value of $317.14 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the Ecolab narrative can be challenged if softer industrial demand persists or if tariffs and cost pressures squeeze margins more than pricing actions can offset.

Find out about the key risks to this Ecolab narrative.

Another View: What Ecolab's P/E Says About Valuation Risk

While the narrative fair value suggests Ecolab could be 17% undervalued, the market pricing using earnings tells a different story. Ecolab trades on a P/E of 35.2x, compared with 25.2x for the US Chemicals industry, 22.1x for peers, and a fair ratio of 24.6x that the market could move toward over time. If sentiment shifts toward that fair ratio, current buyers would be paying a premium that might leave less room for error. Which signal do you put more weight on: the growth story or the richer multiple?

Story Continues

See what the numbers say about this price — find out in our valuation breakdown.NYSE:ECL P/E Ratio as at Jul 2026

Next Steps

With mixed signals around Ecolab's valuation and future, this is a moment to move quickly, review the full picture, and weigh both the 4 key rewards and 1 important warning sign

Looking for more investment ideas beyond Ecolab?

Before earnings for Ecolab land, take a moment to widen your opportunity set so you are not relying on a single stock or story.

Target stability by reviewing companies screened for resilient balance sheets and fundamentals through the solid balance sheet and fundamentals stocks screener (48 results). Hunt for mispriced quality by scanning the 38 high quality undervalued stocks to find businesses that combine stronger cash flows with more conservative valuations. Spot potential early movers by checking the screener containing 20 high quality undiscovered gems where solid fundamentals have not yet attracted broad attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ECL.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments